Oxford BioMedica (OXBDF) Stock Statistics & Valuation Metrics

Oxford BioMedica has a market cap or net worth of $960.77M. The enterprise value is $747.72M.

Oxford BioMedica has 121,010,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oxford BioMedica’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -11.48%.

The current PE Ratio of Oxford BioMedica is ―. Oxford BioMedica’s PEG ratio is 0.64.

In the last 12 months, Oxford BioMedica had revenue of 168.74M and earned -30.13M in profits. Earnings per share was -0.27.

In the last 12 months, operating cash flow was -5.45M and capital expenditures -4.76M, giving a free cash flow of -10.21M billion.

Oxford BioMedica pays an annual dividend of ―, resulting in a dividend yield of ―

Oxford BioMedica upcoming earnings date is Sep 23, 2026, TBA (Confirmed).

Oxford BioMedica as a current ratio of 2.20, with Debt / Equity ratio of 162.16%

In the past 12 months, Oxford BioMedica has paid -1.29M in taxes.

Oxford BioMedica EV to EBITDA ratio is -81.33, with an EV/FCF ratio of -72.63.

Oxford BioMedica has $96.88M in cash and marketable securities with $148.13M in debt, giving a net cash position of -$51.24M billion.

Gross margin is 39.10%, with operating margin of -17.55%, and net profit margin of -17.85%.

The average price target for Oxford BioMedica is $13.41, which is 11.43% higher than the current price. The consensus rating is Moderate Buy